Evidence map›Paper›PMID 26307673›Full record

ArticleNature communications2015

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.

Alejandro Conde-Perez, Gwendoline Gros, Christine Longvert, Malin Pedersen, Valérie Petit, Zackie Aktary, Amaya Viros, Franck Gesbert, Véronique Delmas, Florian Rambow and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. L-cell-specificActa pharmaceutica Sinica. B · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Melanoma Risk and Melanocyte Biology.Acta dermato-venereologica · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 4 countries.

Alejandro Conde-PerezNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Gwendoline GrosNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Christine LongvertNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Malin PedersenTargeted Therapy Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
Valérie PetitNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Zackie AktaryNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Amaya VirosMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK.
Franck GesbertNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Véronique DelmasNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Florian RambowNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Boris C BastianDepartments of Dermatology and Pathology and UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143, USA.
Andrew D CampbellThe Beatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Sophie ColomboNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Isabel PuigNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Alfonso BellacosaFox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Owen SansomThe Beatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Richard MaraisMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK.
Leon C L T Van KempenDepartment of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen 6500 HB, The Netherlands.
Lionel LarueNormal and Pathological Development of Melanocytes, Institut Curie, Orsay 91405, France.
Institut Curie · FRCentre National de la Recherche Scientifique · FRCancer Research UK Scotland Institute · GBCancer Research UK Manchester Institute · GBFox Chase Cancer Center · USInstitute of Cancer Research · GBRadboud University Nijmegen · NLUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of Manchester · GB

Funding

Cancer Research UK 17240Cancer Research UK 19279Cancer Research UK 21139Cancer Research UK C5759/A12328Wellcome Trust WT100181/Z/12/Z
6 · The paper itself

Abstract

Loss of the tumour suppressor PTEN is frequent in human melanoma, results in MAPK activation, suppresses senescence and mediates metastatic behaviour. How PTEN loss mediates these effects is unknown. Here we show that loss of PTEN in epithelial and melanocytic cell lines induces the nuclear localization and transcriptional activation of β-catenin independent of the PI3K-AKT-GSK3β axis. The absence of PTEN leads to caveolin-1 (CAV1)-dependent β-catenin transcriptional modulation in vitro, cooperates with NRAS(Q61K) to initiate melanomagenesis in vivo and induces efficient metastasis formation associated with E-cadherin internalization. The CAV1-β-catenin axis is mediated by a feedback loop in which β-catenin represses transcription of miR-199a-5p and miR-203, which suppress the levels of CAV1 mRNA in melanoma cells. These data reveal a mechanism by which loss of PTEN increases CAV1-mediated dissociation of β-catenin from membranous E-cadherin, which may promote senescence bypass and metastasis.

Indexed as

Animalsbeta CateninBlotting, WesternCadherinsCaveolin 1Cell Line, TumorFeedback, PhysiologicalGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGTP PhosphohydrolasesHumansImmunohistochemistryMelanocytesMelanomaMembrane ProteinsMicebeta CateninCadherinsCaveolin 1Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanGsk3b protein, mouseGTP PhosphohydrolasesMembrane ProteinsMicroRNAsmirn199 microRNA, humanMirn199 microRNA, mouseMIRN203 microRNA, humanMIRN203 microRNA, mouseNRAS protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN Phosphohydrolase

Identifiers

PMID26307673
PMCPMC4560817
OpenAlexW1867333488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.